NVCR Q2 2020 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q2 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$116M+33.7% YoY

Gross Profit

$90M78.0% margin

Operating Income

$7M5.8% margin

Net Income

$2M1.4% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

+13.8%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$9M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$529M

Total Liabilities

$261M

Stockholders' Equity

$268M

Cash & Equivalents

$197M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$116M	$87M	+33.7%
Gross Profit	$90M	$66M	+37.9%
Operating Income	$7M	$1M	+457.5%
Net Income	$2M	-$1M	+230.3%

Geographic Segments

UNITED STATES

$81M70%

GERMANY

$21M19%

JAPAN

$7M6%

EMEA, Exculding Germany

$4M3%

CHINA

$2M2%